F628-1709 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-{[4-(5-cyclopentyl-1,2,4-oxadiazol-3-yl)phenyl]formamido}acetamide

F628-1709 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-{[4-(5-cyclopentyl-1,2,4-oxadiazol-3-yl)phenyl]formamido}acetamide
F628-1709 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-{[4-(5-cyclopentyl-1,2,4-oxadiazol-3-yl)phenyl]formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F628-1709
N-(2H-1,3-benzodioxol-5-yl)-2-{[4-(5-cyclopentyl-1,2,4-oxadiazol-3-yl)phenyl]formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F628-1709

Molecular Formula

C23H22N4O5 (C23 H22 N4 O5)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-2-{[4-(5-cyclopentyl-1,2,4-oxadiazol-3-yl)phenyl]formamido}acetamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-2-{[4-(5-cyclopentyl-124-oxadiazol-3-yl)phenyl]formamido}acetamide

SMILES

O=C(CNC(c(cc1)ccc1-c1noc(C2CCCC2)n1)=O)Nc(cc1)cc2c1OCO2

InChI

InChI=1S/C23H22N4O5/c28-20(25-17-9-10-18-19(11-17)31-13-30-18)12-24-22(29)15-7-5-14(6-8-15)21-26-23(32-27-21)16-3-1-2-4-16/h5-11,16H,1-4,12-13H2,(H,24,29)(H,25,28)

InChI Key

GEVLMAFZCSDWHY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27180052

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.45

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.698

Distribution Coefficient, logD

4.698

Water Solubility, LogSw

-4.75

Polar Surface Area

96.880

Acid Dissociation Constant (pKa)

11.74

Base Dissociation Constant (pKb)

1.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

F628-1709 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SH2 Library (10483 compounds)

Targeted Diversity Library (40567 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Endocrine
  • Infections
  • Immune system
  • animal
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with F628-1709 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F628-1709?
Check Price and Availability of F628-1709, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F628-1709 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F628-1709
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F628-1709
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F628-1709 available by request